Vir Biotechnology, Inc.
VIR· Nasdaq
Released Feb 26, 2025, after the close
10-K filed Feb 27, 2025, 58 days after period end · 0001628280-25-008245
derived · Computed from the longer spans the company filed.
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures |
|---|---|---|---|---|
| Revenue | $12.37M | $16.79M | $49.41M | $812.76M |
| Net Income | -$104.59M |
Vir Biotechnology, Inc. · CIK 1706431 · Engraved from SEC EDGAR
| -$115.92M |
| -$101.60M |
| $525.25M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.